期刊文献+

18F-FDG PET/CT联合肿瘤标志物诊断术前非小细胞肺癌纵隔淋巴结转移的价值 被引量:9

Value of 18F-FDG PET/CT combined with tumor markers in diagnosis of mediastinal lymph node metastasis of non-small cell lung cancer before operation
下载PDF
导出
摘要 目的:探讨18F-FDG PET/CT联合肿瘤标志物诊断术前非小细胞肺癌(NSCLC)纵隔淋巴结转移的价值。方法:回顾性分析81例根治后经病理证实为NSCLC患者的临床资料、病理结果及18F-FDG PET/CT代谢参数。应用多元Logistic回归分析筛选纵隔淋巴结转移的影响因素,建立预测纵隔淋巴结转移的多元Logistic回归模型。采用受试者工作特征曲线(ROC曲线)及ROC曲线下面积(AUC)比较各个诊断因素的诊断效能。结果:纵隔淋巴结转移组的淋巴结最大标准摄取值(SUV max)、纵隔淋巴结短径、糖类抗原153(CA153)与无转移组比较,差异有统计学意义(均P<0.05)。多因素分析示,SUV max≥3.46(OR=3.72,95%CI:0.95~14.55)、淋巴结短径≥7.55 mm(OR=13.49,95%CI:3.27~55.63)、CA153≥16.70 ng/mL(OR=5.09,95%CI:1.08~24.08)是NSCLC纵隔淋巴结转移的独立危险因素(P<0.05)。与淋巴结SUV max、淋巴结短径、CA153的AUC比较,Logistic模型AUC最高(AUC=0.84,95%CI:0.75~0.92),特异度、敏感度分别为79.1%和78.8%。结论:结合CA153、纵隔淋巴结短径及纵隔淋巴结SUV max建立的Logistic诊断模型,提高了对术前NSCLC纵隔淋巴结转移的诊断能力,具有较高的临床价值。 Objective:To assess the value of 18F-FDG PET/CT combined with tumor markers in the diagnosis of lymph node metastasis in patients with non-small cell lung cancer(NSCLC)before operation.Methods:The clinical data,pathological results and 18F-FDG PET/CT metabolic parameters of 81 patients with NSCLC were analyzed retrospectively.Multivariate Logistic regression analysis was used to screen the factors for the diagnosis of mediastinal lymph node metastasis,and a logistic regression model was established to diagnose mediastinal lymph node metastasis.Receiver operating characteristic(ROC)curve was used to compare the diagnostic effectiveness of each diagnostic factor according to the area under ROC curve(AUC).Results:There were significant difference in maximum standard uptake value(SUV max),short diameter of mediastinal lymph node,and carbohydrate antigen 153(CA153)between the mediastinal lymph node metastasis group and the non-metastasis group(P<0.05).Multivariate Logistic regression analysis showed that the SUV max≥3.46 of mediastinal lymph node(OR=3.72,95%CI:0.95-14.55),short diameter≥7.55 mm of mediastinal lymph node(OR=13.49,95%CI:3.27-55.63),and CA153≥16.70 ng/mL(OR=5.09,95%CI:1.08-24.08)were the risk factors for mediastinal lymph node metastasis(P<0.05).ROC curve showed that compared with the AUC value of SUV max,short diameter and CA153,the AUC value of Logistic model was the largest(AUC=0.84),and its specificity and sensitivity were 79.1%and 78.8%,respectively.Conclusion:The Logistic diagnosis model established by combining CA153 with short diameter and SUV max of mediastinal lymph node improves the diagnostic efficacy of preoperative NSCLC mediastinal lymph node metastasis and it has high clinical value.
作者 张涵 蒲维维 张实来 莫少洲 仇冰清 柴华 韦琳琳 肖国有 Zhang Han;Pu Weiwei;Zhang Shilai;Mo Shaozhou;Qiu Bingqing;Chai Hua;Wei Linlin;Xiao Guoyou(Department of Nuclear Medicine,The Affiliated Tumor Hospital of Guangxi Medical University,Nanning 530021,China)
出处 《广西医科大学学报》 CAS 2020年第12期2215-2219,共5页 Journal of Guangxi Medical University
基金 广西重点研发计划资助项目(No.桂科AB19110015) 广西医疗卫生适宜技术开发与推广应用资助项目(No.Z20190595) 广西医科大学青年基金课题资助项目(No.GXMUYSF201819)。
关键词 18F-FDG PET/CT 非小细胞肺癌 纵隔淋巴结转移 肿瘤标志物 18F-FDG PET/CT non-small cell lung cancer mediastinal lymph node metastasis tumor marker
  • 相关文献

参考文献5

二级参考文献56

  • 1俞建华,王荣福.正电子发射断层代谢显像标准摄取值及定量分析的问题与对策[J].中国医学影像技术,2005,21(5):791-794. 被引量:11
  • 2张建华,王荣福.符合探测正电子双时相显像临床应用的研究进展[J].北京医学,2005,27(7):433-438. 被引量:6
  • 3黄国俊,张德超,毛友生,李鉴,王永岗,王大力,薛奇,高树庚,张良泽,雷文东,高禹舜,赵峻,黄进丰,杨昆,苏凯,朱守营,韦森,冯飞跃.肺癌的临床分期与外科病理TNM分期比较[J].中华肿瘤杂志,2005,27(9):551-553. 被引量:22
  • 4黄健,王茂生,梁宇强.肺癌淋巴结转移特点及转移方式的临床分析[J].中国医师杂志,2006,8(2):168-170. 被引量:6
  • 5Rusch V W, Asamura H, Watanabe H, et al. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classifica- tion for lung cancer[J]. J Thorae Oncol, 2009,4 ( 5 ) : 568- 577.
  • 6Naruke T, Suemasu K , Ishikawa S. Lymph node mapping andcurability at various levels of metastasis in resected lung canacr [J]. J Thorac Cardiovasc Surg, 1978,76(6) .832-839.
  • 7Okada M,Tsubota N,Yashimura M,et al. Prognosis of complete ly resected pN2 non-small cell lung carcinomas~what is the signif icant node that affects survival.'?[J]. J Thorac Cardiovasc Surg 1999,118(2) :270- 275.
  • 8Sivrikoz C M, Ak I,Simsek F S, et al. Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non small cell lung carcinoma[J]. Thorac Cardiovasc Surg,2012, 60(2): 116-121.
  • 9Li X, Zhang H, Xing L,el al. Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: a multicenter study[J]. Radiother Oneol,2012,102(2): 246-250.
  • 10Azad A, Chionh F, Scott A M, et al . High Impact of 18F FDG PET on management and prognostic stratification of newly diag nosed small cell lung cancer[J]. Mol Imaging Biol, 2010, 12 (4) 443-451.

共引文献72

同被引文献89

引证文献9

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部